MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0113862073373659260101094951

Медицинская библиотека · Combinatorial chemistry & high throughput screening · 2026

Arctigenin Induces Mitochondrial Apoptosis in Ovarian Cancer Cells by Downregulating Bcl2L12 Expression.

Yang Ying, Cui Peng, Chen Weiyan, Wang Qun, Ji Tianmin, Wang Jiaxin, Zhao Jiao, Song Nan

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Ovarian cancer remains one of the most lethal gynecological malignancies because of late diagnosis, drug resistance, and limited treatment efficacy. This study explored the anti-apoptotic role of BCL2-like protein 12 (BCL2L12) and whether arctigenin induces apoptosis by targeting BCL2L12.

METHODS

SK-OV-3 and OVCAR-3 ovarian cancer cells were subjected to BCL2L12 knockdown or overexpression. Cell viability, proliferation, and apoptosis were evaluated by CCK-8, colony formation, and Annexin V/PI flow cytometry. Mitochondrial membrane potential and reactive oxygen species (ROS) levels were assessed using JC-1 and DCFH-DA staining, respectively, and apoptosis- and autophagy-related proteins were examined by western blotting. Public databases (TCGA, GTEx, CSIOVDB, Kaplan-Meier Plotter) were used to evaluate BCL2L12 expression and prognosis.

RESULTS

BCL2L12 was markedly upregulated in ovarian cancer and correlated with advanced stage and poor survival. Silencing BCL2L12 reduced cell growth, disrupted mitochondrial homeostasis, increased ROS accumulation, and enhanced caspase-3/7-dependent apoptosis while inhibiting autophagy. Arctigenin inhibited cell proliferation, downregulated BCL2L12, and induced mitochondrial apoptosis accompanied by ROS elevation and caspase-3/7 activation, whereas BCL2L12 overexpression attenuated these effects.

DISCUSSION: BCL2L12 acts as an anti-apoptotic factor in ovarian cancer by maintaining mitochondrial integrity and suppressing caspase-3/7 activation. Arctigenin overcomes this survival advantage by suppressing BCL2L12 and triggering mitochondrial apoptosis. Limitations include validation only in two cell lines and the lack of direct enzymatic assays for caspase-3/7 activity.

CONCLUSION

Arctigenin induces mitochondrial apoptosis in ovarian cancer by downregulating BCL2L12, supporting its potential as a low-toxicity therapeutic candidate.

Для цитирования: Yang Ying, Cui Peng, Chen Weiyan, Wang Qun, Ji Tianmin, Wang Jiaxin, Zhao Jiao, Song Nan. Arctigenin Induces Mitochondrial Apoptosis in Ovarian Cancer Cells by Downregulating Bcl2L12 Expression.. Combinatorial chemistry & high throughput screening. 2026. DOI: 10.2174/0113862073373659260101094951.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.